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Abstract
Background: Obesity is one of the greatest challenges in primary health care. The BMI describes fat mass and
waist circumference (WC) fat distribution and total metabolic and cardiovascular risk. It was aim of the present
study to assess the prevalence of a) overweight and obesity and b) an increased and high WC in adults seeking
primary care in Germany and to describe the associations of both measures with cardiovascular risk factors and
prognosis.
Methods: This was a point prevalence study with 1,511 primary care physicians and 35,869 adult patients in 2005.
Bodyweight, height and waist circumference was measured and blood samples taken to determine the presence
of cardiovascular risk factors, including lipids, blood pressure, fasting glucose, low physical activity, smoking and
family history of myocardial infarction. We calculated rate ratios stratified for age and gender.
Results: There was a high prevalence of overweight (45.7% male [95%CI 44.9–46.5]; 30.6% female [95%CI 30.0–
31.2]) and obesity (24.7% male [95%CI 24.0–25.4]; 23.3% female [95%CI 22.8–23.9]). 36.4% of male [95%CI 35.6–
37.2] and 41.5% of female [95%CI 40.8–42.1] had a high WC (male > 102, female > 88 cm). A high WC in addition
to an overweight BMI identified patients with more risk factors (male: mean of 3.93 risk factors (RF) at a WC >
102 cm vs. 2.88 RF in patients ≤ 94 cm; female 3.58 RF at a WC > 88 cm vs. 2.41 RF ≤ 80 cm).
Conclusion: There is a high prevalence of obesity (24.7% of male and 23.3% of female) and, in particular,
abdominal obesity (36.4% of male and 41.5% of female) in adults attending a primary care physician in Germany.
The determination of the BMI is sufficient to assess risk in normal weight and obese patients, while a high WC
identifies high risk patients from within the overweight group.
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Background
Overweight and obese persons have an increased preva-
lence of cardiometabolic risk factors compared to patients
with normal weight, especially when they are abdomi-
nally obese. Different anthropometric measures like
weight, height, waist- and/or hip circumference, direct
measurements of abdominal fat using MRI scans and var-
ious computations of these variables have been proposed
to identify patients with an increased risk for developing
diabetes and cardiovascular events [1].
Body mass index (BMI) is the most widely accepted meas-
ure of obesity in populations and in clinical practice.
Therefore, most reports on the prevalence of obesity and
its trends over time and distribution among regions are
based on the determination of BMI. Using this definition
the World Health Organization (WHO) estimated that
over 1 billion people are overweight globally, and if the
current trend continues, that this number will increase to
1.5 billion by 2015 [2]. Previous studies reported rates of
38% for overweight and 20% for obesity in the adult pop-
ulation in Germany [3,4].
While the BMI is, with limitations, generally a proper
measure of total body fat measuring the waist circumfer-
ence provides insight into the distribution of body fat. It
discriminates persons with abdominal obesity from those
with a more gluteal-femoral fat deposition. Abdominal
obesity has been shown to be associated with an increased
cardiovascular risk [5-8] and its use as the central variable
in defining persons with the metabolic syndrome high-
lights its role as a risk indicator. Generally, a cut-off of >
102 cm in men and > 88 cm in women (which is predict-
ing obesity in Scottish people [9]) is accepted indicating a
clearly elevated health risk, but already cut-offs of > 94/>
80 cm (termed abdominal overweight, which is predicting
overweight [9]) have been found to be associated with a
moderately increased cardiovascular risk among Cauca-
sians [10].
Primary care physicians are besides public health initia-
tives the most promising party to improve the manage-
ment of overweight and obesity since they are the
gatekeepers of the healthcare system in most countries.
Therefore, nationwide data from the primary care sector
are needed to recognize the dimension of this public
health problem and to develop strategies to handle it. The
present analysis is based on the dataset of the "German
Metabolic and Cardiovascular Risk Project" (GEMCAS),
which is a nationwide point prevalence study in 35,869
adult primary care attendees in Germany [11]. Aim of this
study was to assess the prevalence of overweight and obes-
ity and the prevalence of an increased waist circumference
in primary care and to study the relationship of these
anthropometric variables to the presence of cardiovascu-
lar risk factors in defined subpopulations.
Methods
Study design and participating physicians
The design of the present study has been described earlier
[11]. It was a 2-week cross-sectional prevalence study at
General practitioners' and internists' offices using a strati-
fied, randomized sampling method for physician selec-
tion. Ethical approval was granted from the local ethics
committee of the University Hospital of the University
Duisburg-Essen, Germany.
Study population
The study population comprised consecutive patients
with an age of 18 years and above with either gender who
visited their GP at the participating sites on the day of the
survey. The only reasons for exclusion from the study were
conditions that made it impossible for the patient to par-
ticipate (serious disabilities or diseases), acute emergen-
cies, or pregnancies and breast-feeding within the
previous 3 months. Participating GPs and their staff
assessed the patients with a standardized questionnaire
with a focus on cardiovascular risk factors and basic data
on sociodemographic as well as anamnestic information
and life style. In total, 1,511 general practices (8.75% of
initially contacted random sample of 17,271 physicians)
from 397 out of 438 German cities and administrative dis-
tricts enrolled 35,869 patients (age range: 18–99 years,
women 61.1%).
Diagnostic procedures
Body weight and height were provided by the treating phy-
sician (or nurse) indicating whether measured (1/3rd of
cases) or anamnestic data (about 2/3rd) were used. Over-
weight was defined as a Body Mass Index (BMI) of ≥ 25
and < 30 kg/m2; obesity as a BMI of ≥ 30 kg/m2. Waist cir-
cumference (WC) was measured with a common tape pro-
vided to all physicians and measured midway between the
last rib and the highest part of the iliac crest in a standard-
ized manner. A high WC was diagnosed > 102 cm in men
and > 88 cm in women. Blood glucose: Initial capillary
blood glucose (BG) quick test was performed independ-
ent of the fasting status to identify all patients with a BG
concentration of < 5.6 mmol/L or those with a BG concen-
tration of ≥ 11.1 mmol/L. Patients with a non-fasting BG
level of 5.6 mmol/L and < 11.1 mmol/L were scheduled
for a follow-up visit within the following 2 weeks for a sec-
ond fasting blood sample. Additionally, venous blood
samples were collected and analyzed for levels of glucose,
LDL-cholesterol, HDL-cholesterol, total cholesterol and
triglycerides using enzymatic assays (Roche Hitachi
MODULAR Systems) in a central laboratory.BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
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Calculation of the PROCAM and SCORE cardiovascular 
risk scores
The PROCAM Score was used to calculate the 10-year risk
for cardiovascular morbidity [12]. The score is computed
using the following 8 independent risk variables, ranked
in order of importance: age, LDL-cholesterol, smoking,
HDL-cholesterol, systolic blood pressure, family history
of premature myocardial infarction, diabetes mellitus,
and triglycerides. Analyses were also done using the
SCORE classification [13]. The following parameters were
used: sex, age, total cholesterol, systolic BP, and smoking
status.
Statistical analyses
For the main variables of the study, basic descriptive sta-
tistics, number of observations, mean, standard deviation,
median, complemented by 95% confidence intervals for
prevalences were calculated. We calculated prevalence rate
ratios (PRRs) stratified for age and gender. All statistical
analyses were conducted using the statistical software
package SAS 9.1 (SAS Institute, Cary, NC, USA) [14].
Results
Sample characteristics
35,869 patients from the GEMCAS study were the basis
for the present analysis. Baseline characteristics have been
reported previously [11,15]. In short, 61.1% of patients
were female; mean age was 51.7 ± 16.1 years with an aver-
age BMI of 27.0 ± 5.2 kg/m2. 54.2% were smokers either
presently (25.1%) or in the past (29.1%). Any cardiovas-
cular disease was present in 16.3% of patients (n = 5,535)
with a history of myocardial infarction or acute coronary
syndromes being the most frequent diagnoses (n = 1,968,
12.3%).
Prevalence of overweight using BMI and WC thresholds
In men, the prevalence of overweight was 45.7% and of
obesity 24.7% (Figure 1 and Table 1). There was an age-
dependent increase in BMI from the age group 18–34
until 65–74 with a slight decline in the prevalence of over-
weight (-0.5%) and a substantial decline of obesity (-
11.1%) thereafter. 26.2% of patients had moderately
increased waist circumference (WC > 94 & ≤ 102 cm),
36.4% had a high WC (> 102 cm). Again, there was an
age-related increase until the age group 65–74; the pro-
portion of patients with an increased WC was comparable
in the elderly, while the prevalence of a high WC dropped
by 5.3%.
Figure 2 and Table 1 show the respective prevalence rates
of anthropometric variables in women. The prevalence of
obesity was 23.3% and comparable to male while the rate
of overweight was substantially lower than in male
(30.6% in women vs. 45.7%). Again, there was an age-
Table 1: Overweight and obesity (BMI) and waist circumference (WC) in primary care
BMI WC
25,0 – 29,9 kg/m2 ≥ 30,0 kg/m2 > 94 & ≤ 102 cm ()
> 80 & ≤ 88 cm ()
> 102 cm ()
> 88 cm ()
%9 5 % C I%9 5 % C I % 9 5 % C I %9 5 % C I
18–34
male 31.2 [29.1;33.3] 13.1 [11.6;14.7] 14.0 [12.5;15.7] 12.8 [11.4;14.4]
female 18.0 [16.8;19.3] 12.8 [11.7;13.9] 14.2 [13.1;15.4] 19.2 [18.0;20.6]
35–44
male 42.9 [40.9;45.0] 22.0 [20.2;23.7] 23.3 [21.5;25.1] 25.7 [24.0;27.6]
female 24.5 [23.2;25.8] 16.7 [15.6;17.8] 20.1 [18.9;21.4] 27.9 [26.6;29.3]
45–54
male 45.2 [43.4;47.0] 27.7 [26.1;29.3] 28.6 [27.0;30.3] 36.6 [34.8;38.3]
female 30.6 [29.3;31.9] 24.5 [23.3;25.7] 21.8 [20.7;23.0] 40.5 [39.1;41.9]
55–64
male 50.3 [48.5;52.1] 28.6 [27.0;30.3] 28.4 [26.8;30.0] 44.3 [42.5;46.1]
female 36.0 [34.5;37.5] 30.3 [28.9;31.8] 23.0 [21.7;24.3] 52.6 [51.0;54.2]
65–74
male 51.6 [49.7;53.5] 30.0 [28.2;31.8] 30.2 [28.5;32.0] 49.7 [47.8;51.6]
female 40.3 [38.6;42.0] 33.2 [31.6;34.9] 21.7 [20.2;23.1] 63.2 [61.5;64.9]
75+
male 51.1 [48.2;54.0] 19.5 [17.3;21.9] 30.7 [28.0;33.4] 44.4 [41.5;47.3]
female 41.2 [39.0;43.5] 24.5 [22.5;26.5] 24.1 [22.1;26.1] 58.3 [56.0;60.6]
Total
male 45.7 [44.9;46.5] 24.7 [24.0;25.4] 26.2 [25.5;26.9] 36.4 [35.6;37.2]
female 30.6 [30.0;31.2] 23.3 [22.8;23.9] 20.6 [20.1;21.1] 41.5 [40.8;42.1]BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
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related increase in prevalence with a decline in the preva-
lence of obesity beyond an age of 74 years. A high WC (>
88 cm) was substantially more frequent (41.5%, total)
than obesity with a peak in the age group 65–74 years
(63.2%). The prevalence rates of an increased WC (> 80
and  ≤ 88 cm) were comparable between age groups
(between 20.1 and 24.1%) except in the young (14.2%).
Proportion of patients with an increased WC stratified by 
BMI subgroups
Most obese patients had a high waist circumference
(87.9% of male and 94.7% of female patients) with lower
rates in the young (71.1% of male, 87.8% of female).
Most normal-weight patients had a normal waist circum-
ference (83.5% of male and 73.0% of female patients)
with a decline in the elderly (60.2% male, 42.5% female).
However, only 39.8% of normal-weight men and 57.4%
of normal-weight women in the age group beyond 74 had
a normal or only elevated WC. Patients in the overweight
BMI group Figure 3 had the greatest heterogeneity in WC.
27.1% of overweight men had a normal WC, 42.3% an
increased and 30.6% a high WC (women 13.4, 33.1,
53.5%). The proportion of overweight patients with a nor-
mal WC was lowest in the highest age group (13.9% male,
6.5% female). On the other hand, young overweight male
patients had a normal waist circumference in 59.4%
(female 30.4%).
Cardiovascular risk factors in overweight patients 
depending on WC
Given the diversity of overweight patients in terms of WC
it seemed to be of particular importance to examine
whether these patients also differ in the prevalence of car-
diovascular risk factors. The risk factors assessed are dis-
played in table 1. In both genders, a high WC was
associated with an increased prevalence of high triglycer-
Body Mass Index (BMI) and Waist Circumference (WC) in male primary care patients by age groups (in %) Figure 1
Body Mass Index (BMI) and Waist Circumference (WC) in male primary care patients by age groups (in %).
14.0
23.3
28.6 28.4
30.2 30.7
26.2
12.8
25.7
36.6
44.3
49.7
44.4
36.4
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
18-34 35-44 45-54 55-64 65-74 75+ Total
%
 
o
f
 
a
g
e
 
g
r
o
u
p
 
(
m
a
l
e
)
WC > 94 & <= 102 cm WC > 102 cm
31.2
42.9
45.2
50.3
51.6 51.1
45.7
13.1
22
27.7 28.6
30
19.5
24.7
0
10
20
30
40
50
60
70
18-34 35-44 45-54 55-64 65-74 75+ Total
%
 
o
f
 
a
g
e
 
g
r
o
u
p
 
(
m
a
l
e
)
BMI >=25 & < 30 kg/m2 BMI >= 30 kg/m2BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
Page 5 of 12
(page number not for citation purposes)
ides (> 150 mg/dL), a high blood pressure (> 140/90
mmHg), an increased fasting plasma glucose (> 100 mg/
dL), the presence of diabetes mellitus and the mean
number of risk factors (for individual figures see Table 2
&3). A family history of myocardial infarction on the
other hand was not more frequent in patients with a high
WC as compared to patients with a normal WC. The prev-
alence of smoking was significantly lower in overweight
men with an elevated and high WC but not in women.
The relation of WC to high LDL-cholesterol, low physical
activity and low HDL-cholesterol was not uniform
throughout age groups and genders. An elevated LDL-cho-
lesterol (> 115 mg/dl) was slightly more frequent in
patients with a high WC, but not in all age groups. The
same was true for low physical activity. A low HDL-choles-
terol was more prevalent in patients with a high WC
except in the elderly (≥ 65 years).
PROCAM and SCORE Score per BMI and WC
In Table 4 and 5, BMI and WC categories are displayed
against each other and are stratified by gender. Table 4
reports the PROCAM Score (risk of a cardiovascular event
within the next 10 years). It shows that there was a steady
increase in risk in both genders from the upper left hand
(low BMI and WC) to the lower right hand (high BMI and
high WC; mean adjusted risk in male 6.18%, mean
adjusted risk in female 1.82%). Furthermore, the risk in
the highest risk category in females (max. 1.82%) was
even lower than in the lowest male risk category (min.
3.78%). The same was true for the SCORE Score (risk of
cardiovascular death within the next 10 years). Again,
patients with a high BMI and high WC had the highest risk
(male adjusted max. 2.61%; female adjusted max. 1.63).
Overall female patients were at a substantially lower risk
(max. 1.63%) than male patients (min. 1.90%).
Body Mass Index (BMI) and Waist Circumference (WC) in female primary care patients by age groups (in %) Figure 2
Body Mass Index (BMI) and Waist Circumference (WC) in female primary care patients by age groups (in %).
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Discussion
Epidemiological research in primary care is, different from
population-based samples, highly relevant when investi-
gating topics related to physician – patient interaction.
Primary care in Germany is characterized by a high patient
load of about 73 consultations per day [16], which is
much higher than in other countries in Europe and world-
wide. Straight and easy to follow rules for screening and
detection of cardiovascular disease are warranted to
ensure, that busy clinical routine does not detract from
cardiovascular prevention and chronic disease treatment.
Obesity and in particular abdominal obesity has been rec-
ognized to be linked to an increase in cardiovascular risk
and therefore the present analysis on the interrelationship
of both measures and their relation to cardiovascular risk
has been conducted.
The present analysis, based on data derived from more
than 35,869 adult primary care attendees, uncovered sev-
eral key aspects of overweight and obesity in primary care:
1) it documents a very high prevalence of overweight
(36.5%) and obesity (23.9%) and of an increased and
high WC in primary care practice in 2005, 2) it shows that
a high waist circumference identifies patients with an
increased cardiovascular risk even within the normal
weight, overweight and obese patient group, 3) it con-
firms a tight relationship between waist circumference
and an increase in cardiovascular risk and 4) it highlights
a remarkable risk increase with BMI, WC and the combi-
nation of both measures.
Prevalence of (abdominal) obesity in adults seeking 
primary care
Although difficult to compare with other studies due to
considerable a difference in methods and sampling the
Proportion of patients with a normal, increased and high WC in the overweight BMI group (in %) Figure 3
Proportion of patients with a normal, increased and high WC in the overweight BMI group (in %).
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Table 2: Cardiovascular risk factors in overweight men split into WC categories
Men BMI ≥ 25 & < 30 kg/m2
≤ 94 cm > 94 & ≤ 102 cm > 102 cm
% % PRR [95%CI] % PRR [95%CI]
LDL > 115 mg/dl
< 45 (yrs) 60.93 67.75 1.11 [1.03;1.21] 68.44 1.12 [1.01;1.25]
45–64 (yrs) 70.36 72.91 1.04 [0.98;1.10] 68.79 0.98 [0.91;1.05]
≥ 65(yrs) 64.31 63.07 0.98 [0.89;1.09] 59.95 0.93 [0.84;1.03]
Total 65.15 68.74 1.06 [1.01;1.10] 64.95 1.00 [0.95:1.05]
TG > 150 mg/dl
< 45 (yrs) 38.68 53.24 1.38 [1.22;1.55] 60.62 1.57 [1.37;1.80]
45–64 (yrs) 46.35 50.95 1.10 [1.00;1.21] 59.79 1.29 [1.17;1.42]
≥ 65(yrs) 34.98 43.76 1.25 [1.05;1.49] 49.69 1.42 [1.19;1.69]
Total 41.04 49.17 1.20 [1.12;1.28] 55.56 1.35 [1.26;1.45]
RR ≥ 140/90 mmHg
< 45 (yrs) 15.31 19.03 1.24 [0.98;1.58] 26.32 1.72 [1.31;2.26]
45–64 (yrs) 24.03 29.00 1.21 [1.03;1.41] 34.71 1.44 [1.23;1.70]
≥ 65(yrs) 36.40 37.99 1.04 [0.87;1.25] 40.00 1.10 [0.92;1.31]
Total 22.20 29.74 1.34 [1.20;1.49] 36.00 1.62 [1.46;1.80]
Low phys. activity
< 45 (yrs) 64.41 74.64 1.16 [1.08;1.25] 87.05 1.35 [1.26;1.45]
45–64 (yrs) 68.54 74.82 1.09 [1.03;1.16] 80.77 1.18 [1.11;1.25]
≥ 65(yrs) 68.63 74.78 1.09 [1.00;1.19] 81.42 1.19 [1.09;1.29]
Total 66.71 74.77 1.12 [1.08;1.17] 81.79 1.23 [1.18;1.28]
HDL < 50 bzw. < 40
< 45 (yrs) 12.35 18.41 1.49 [1.15;1.93] 17.04 1.38 [0.98;1.95]
45–64 (yrs) 8.27 11.62 1.41 [1.04;1.89] 13.64 1.65 [1.21;2.24]
≥ 65(yrs) 8.13 10.46 1.29 [0.83;2.00] 12.36 1.52 [0.99;2.34]
Total 10.07 12.67 1.26 [1.06;1.50] 13.49 1.34 [1.12;1.61]
FPG > 100 mg/dl
< 45 (yrs) 11.05 11.65 1.05 [0.69;1.60] 16.42 1.49 [0.92;2.39]
45–64 (yrs) 18.13 28.28 1.56 [1.23;1.99] 34.98 1.93 [1.52;2.45]
≥ 65(yrs) 32.92 37.35 1.13 [0.89;1.45] 46.37 1.41 [1.11;1.79]
Total 17.74 27.93 1.57 [1.34;1.85] 37.87 2.14 [1.83;2.50]
Smoker
< 45 (yrs) 39.68 36.65 0.92 [0.80;1.06] 38.33 0.97 [0.80;1.16]
45–64 (yrs) 23.47 25.06 1.07 [0.90;1.26] 28.65 1.22 [1.03;1.45]
≥ 65(yrs) 7.17 10.24 1.43 [0.89;2.28] 10.07 1.41 [0.88;2.25]
Total 27.97 22.91 0.82 [0.74;0.91] 21.90 0.78 [0.70;0.88]
MI family history
< 45 (yrs) 20.06 21.09 1.02 [0.82;1.27] 19.71 0.97 [0.71;1.31]
45–64 (yrs) 22.41 22.74 1.05 [0.88;1.25] 22.09 1.04 [0.86;1.27]
≥ 65(yrs) 14.45 12.16 0.86 [0.60;1.21] 15.66 1.10 [0.79;1.53]
Total 20.03 19.25 0.98 [0.87;1.11] 19.08 1.00 [0.87;1.15]
Diabetes
< 45 (yrs) 1.57 3.05 1.94 [0.93;4.03] 3.91 2.49 [1.06;5.84]
45–64 (yrs) 10.39 15.12 1.45 [1.12;1.88] 21.61 2.08 [1.61;2.69]
≥ 65(yrs) 18.44 27.18 1.47 [1.13;1.93] 32.61 1.77 [1.36;2.30]
Total 7.78 16.39 2.11 [1.75;2.53] 24.24 3.11 [2.60;3.74]
Number of risks Mean Mean Mean
< 45 (yrs) 2.68 3.09 3.00
45–64 (yrs) 3.37 3.51 3.39
≥ 65(yrs) 3.90 4.03 3.83
Total 2.88 3.44 3.93
Cardiovascular risk factors are increased in male overweight patients with a high waist circumference (WC). PRR mean prevalence rate ratio; CI, 
confidence interval; FPG, fasting plasma glucose; MI, myocardial infarction. * the mean number of risks reflects the number of risk factors positive 
from the above mentioned.BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
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Table 3: Cardiovascular risk factors in overweight women split into WC categories
Women BMI ≥ 25 & < 30 kg/m2
≤ 80 cm > 80 & ≤ 88 cm > 88 cm
% % PRR [95%CI] % PRR [95%CI]
LDL > 115 mg/dl
< 45 (yrs) 44.47 53.57 1.21 [1.06;1.37] 57.47 1.29 [1.14;1.47]
45–64 (yrs) 68.68 73.81 1.07 [0.99;1.16] 74.92 1.10 [1.01;1.19]
≥ 65(yrs) 71.23 72.38 1.02 [0.91;1.14] 72.27 1.01 [0.91;1.13]
Total 58.44 67.33 1.15 [1.08;1.23] 70.69 1.21 [1.14;12.8]
TG > 150 mg/dl
< 45 (yrs) 13.37 21.40 1.60 [1.20;2.14] 32.20 2.41 [1.83;3.18]
45–64 (yrs) 21.26 31.14 1.46 [1.17;1.83] 42.48 2.00 [1.62;2.47]
≥ 65(yrs) 35.62 37.33 1.05 [0.82;1.34] 47.21 1.33 [1.06;1.66]
Total 20.16 29.68 1.47 [1.27;1.70] 42.39 2.10 [1.83;2.41]
RR ≥ 140/90 mmHg
< 45 (yrs) 4.35 7.50 1.72 [1.01;2.95] 14.29 3.29 [1.99;5.42]
45–64 (yrs) 20.17 23.05 1.14 [0.90;1.45] 29.94 1.48 [1.19;1.85]
≥ 65(yrs) 32.65 37.69 1.15 [0.89;1.49] 41.37 1.27 [1.00;1.61]
Total 15.28 21.85 1.43 [1.20;1.70] 31.44 2.06 [1.75;2.42]
Low phys. activity
< 45 (yrs) 73.25 73.83 1.01 [0.93;1.09] 78.73 1.07 [1.00;1.16]
45–64 (yrs) 68.70 74.09 1.08 [1.00;1.69] 77.84 1.13 [1.05;1.22]
≥ 65(yrs) 76.92 78.81 1.03 [0.93;1.13] 84.63 1.10 [1.00;1.21]
Total 72.05 75.12 1.04 [0.99;1.09] 80.55 1.12 [1.07;1.17]
HDL < 50 bzw. < 40
< 45 (yrs) 10.54 15.93 1.51 [1.08;2.12] 23.61 2.24 [1.63;3.09]
45–64 (yrs) 7.47 11.73 1.57 [1.04;2.36] 15.66 2.10 [1.42;3.09]
≥ 65(yrs) 17.81 11.64 0.65 [0.43;1.00] 19.11 1.07 [0.74;1.55]
Total 10.53 12.98 1.23 [0.99;1.54] 18.45 1.75 [1.43;2.15]
FPG > 100 mg/dl
< 45 (yrs) 3.85 3.30 0.86 [0.31;2.36] 5.48 1.43 [0.57;3.54]
45–64 (yrs) 9.68 15.61 1.61 [0.95;2.73] 21.79 2.25 [1.37;3.71]
≥ 65(yrs) 23.68 26.39 1.11 [0.71;1.74] 34.81 1.47 [0.97;2.23]
Total 10.08 15.36 1.52 [1.10;2.12] 24.32 2.41 [1.77;3.28]
Smoker
< 45 (yrs) 30.13 32.52 1.08 [0.89;1.30] 37.42 1.24 [1.04;1.49]
45–64 (yrs) 17.40 19.90 1.14 [0.88;1.49] 24.97 1.43 [1.12;1.84]
≥ 65(yrs) 5.00 4.23 0.85 [0.37;1.95] 6.16 1.23 [0.58;2.61]
Total 21.06 20.14 0.96 [0.82;1.12] 20.22 0.96 [0.83;1.11]
MI family history
< 45 (yrs) 26.98 25.00 0.93 [0.75;1.15] 26.67 0.97 [0.78;1.19]
45–64 (yrs) 29.28 28.37 0.98 [0.80;1.19] 28.96 0.99 [0.82;1.20]
≥ 65(yrs) 20.16 18.10 0.86 [0.59;1.27] 18.84 0.95 [0.67;1.36]
Total 26.75 24.94 0.93 [0.81;1.07] 24.80 0.94 [0.83;1.07]
Diabetes
< 45 (yrs) 0.51 1.05 2.06 [0.43;9.88] 1.99 3.91 [0.89;17.23]
45–64 (yrs) 4.86 6.07 1.25 [0.74;2.11] 12.34 2.54 [1.57;4.11]
≥ 65(yrs) 13.61 18.03 1.33 [0.85;2.07] 26.65 1.96 [1.30;2.97]
Total 4.39 7.42 1.69 [1.20;2.38] 15.89 3.62 [2.64;4.97]
Number of risks Mean Mean Mean
< 45 (yrs) 2.25 2.51 3.00
45–64 (yrs) 2.59 2.92 3.25
≥ 65(yrs) 3.23 3.58 3.79
Total 2.41 2.90 3.58
Cardiovascular risk factors are increased in female overweight patients with a high waist circumference (WC). PRR mean prevalence rate ratio; CI, 
confidence interval; FPG, fasting plasma glucose; MI, myocardial infarction. * the mean number of risks reflects the number of risk factors positive 
from the above mentioned.BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
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present data indicate a high prevalence of overweight and
obesity in primary health care in Germany. According to
the "Shape of the Nations survey" 39% of all people visit-
ing a primary care physicians worldwide were overweight
or obese; in North America, this proportion was 49%
[17]. In the Netherlands, a population closely resembling
the German population, obesity was observed in 8.9% of
men and 12.4% of women; for overweight these percent-
ages were 42.2% and 30.4%, respectively [18]. On the
other hand, in primary care of the southeastern United
Table 4: PROCAM risk crude (and standardized for age differences in brackets) in relation to BMI and waist circumference.
A. Male ≤ 94 cm > 94 & ≤ 102 cm > 102 cm Total
< 25 kg/m2 3.61 (3.78) [n = 1,800; 
23.41%]
5.84 (4.91) [n = 296; 3.85%] 6.77 (4.63*) [n = 30; 0.39%] 3.97 (4.0) [n = 2,126; 27.65%]
≥ 25& < 30 kg/m2 4.56 (4.64) [n = 1,026; 
13.34%]
6.49 (5.49) [n = 1,564; 
20.34%]
7.68 (5.83) [n = 974; 12.67%] 6.26 (5.35) [n = 3,564; 
46.35%]
≥ 30 kg/m2 6.15 (5.9*) [n = 28; 0.36%] 6.07 (5.96) [n = 230; 2.99%] 7.35 (6.18) [n = 1,742; 
22.65%]
7.19 (6.16) [n = 2,000; 
26.01%]
Total 3.98 (4.12) [n = 2,854; 
37.11%]
6.35 
(5.47) [n = 2,090; 27.18%)
7.46 
(6.05) [n = 2,746; 35.71%)
5.87 (5.22) [7,690; 100.00%]
B. Female ≤ 80 cm > 80 & ≤ 88 cm > 88 cm Total
< 25 kg/m2 0.94 (1.08) [n = 2,438; 
27.50%]
1.35 (1.35) [n = 889; 10.03%] 1.63 (1.62) [n = 223; 2.52%] 1.09 (1.19) [n = 3,550; 
40.05%]
≥ 25& < 30 kg/m2 1.15 (1.23) [n = 360; 4.06%] 1.43 (1.46) [n = 1,008; 
11.37%]
1.85 (1.75) [n = 1,566; 
17.66%]
1.62 (1.59) [n = 2,934; 
33.10%]
≥ 30 kg/m2 1.37 (1.29*) [n = 13; 0.15%] 1.53 (1.5) [n = 96; 1.08%] 1.86 (1.82) [n = 2,272; 
25.63%]
1.85 (1.81) [n = 2,381; 
26.86%]
Total 0.97 (1.1) [n = 2,811; 31.71%] 1.40 (1.41) [n = 1,993; 
22.48%]
1.85 (1.78) [n = 4,061; 
45.81%]
1.47 (1.5) [8865; 100.00%]
[number of patients per patient group with non-missing PROCAM; proportion of all patients with non-missing PROCAM].
PROCAM risk in relation to BMI and waist circumference [12]. N means number of patients with non-missing PROCAM in each cell; % of inner 9 
cells adds up to 100%; the figure displayed is the risk for cardiovascular events for the next 10 years calculated with the PROCAM score 
(standardized for age). Crude/age-standardized mean are reported. * means that the total N in this cell is 30 or below and therefore the direct age 
standardization may have led to unreliable results.
Table 5: SCORE Score in relation to BMI and waist circumference.
A. Male ≤ 94 cm > 94 & ≤ 102 cm > 102 cm Total
< 25 kg/m2 1.86 (1.90) [n = 1,801; 
23.40%]
3.01 (2.25) [n = 295; 3.83%] 3.77 (2.19) [n = 31; 0.40%] 2.05 (1.97) [n = 2,127; 
27.63%]
≥ 25 & < 30 kg/m2 1.99 (2.03) [n = 1024; 
13.30%]
2.98 (2.32) [n = 1,578; 
20.50%]
3.62 (2.45) [n = 977; 12.69%] 2.87 (2.29) [n = 3,579; 
46.49%]
≥ 30 kg/m2 2.22 (2.31*) [n = 27; 0.35%] 2.67 (2.57) [n = 231; 3.00%] 3.42 (2.61) [n = 1,734; 
22.53%]
3.32 (2.6) [n = 1,992; 25.88%]
Total 1.91 (1.95) [n = 2,852; 
37.05%]
2.95 (2.33) [n = 2,104; 
27.33%]
3.50 (2.55) [n = 2,742; 
35.62%]
2.76 (2.29) [7,698; 100.00%]
B. Female ≤ 80 cm > 80 & ≤ 88 cm > 88 cm Total
< 25 kg/m2 0.95 (1.18) [n = 2,585; 
28.15%]
1.32 (1.30) [n = 948; 10.32%] 1.61 (1.52) [n = 235; 2.56%] 1.09 (1.24) [n = 3,768; 
41.03%]
≥ 25 & < 30 kg/m2 1.07 (1.16) [n = 365; 3.97%] 1.38 (1.37) [n = 1031; 
11.23%]
1.82 (1.63) [n = 1,600; 
17.42%]
1.58 (1.5) [n = 2,996; 32.63%]
≥ 30 kg/m2 1.50 (1.71*) [n = 14; 0.15%] 1.30 (1.27) [n = 98; 1.07%] 1.73 (1.63) [n = 2,307; 
25.12%]
1.71 (1.62) [n = 2,419; 
26.34%]
Total 0.97 (1.18) [n = 2,964; 
32.28%]
1.35 (1.34) [n = 2,077; 
22.62%]
1.76 (1.63) [n = 4,142: 
45.11%]
1.41 (1.43) [9,183; 100.00%]
[number of patients per patient group with non-missing SCORE; proportion of all patients with non-missing SCORE].
SCORE Score in relation to BMI and waist circumference [13]. N means number of patients in each cell with non-missing SCORE; % of inner 9 cells 
adds up to 100%; the figure displayed is the risk for cardiovascular death for the next 10 years calculated with the SCORE score. Crude/age-
standardized mean are reported. * means that the total N in this cell is 30 or below and therefore the direct age standardization may have led to 
unreliable results.).BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
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States (1999–2002) substantially higher prevalence rates
for overweight (white women 26%, men 24%) and obes-
ity (white women 36%, men 32%) have been reported
[19]. Previous data from German primary care are availa-
ble for 2001 from the HYDRA- and for 2003 from the
DETECT-study [4,20]. Prevalence rates in 2001 were
37.9% for overweight and 19.4% for obesity, prevalence
rates in 2003 were 37.3% for overweight and 22.5% for
obesity.
36.4% of male and 41.5% of female patients in our pri-
mary care cohort had a high WC (> 102 cm men, > 88 cm
women). This appears high as compared to population-
based samples across Europe [21-26], which one would
expect based on the higher morbidity in a primary care
sample. It is lower, however, as compared to the recent
nationwide DETECT study of 55,518 consecutive German
primary care attendees. In this survey, 43% of male and
53% of female patients met criteria for abdominal obesity
(waist circumference ≥ 102 for men and ≥ 88 for women)
[20]. Methodological differences between the GEMCAS
and the DETECT cohort may account for differences in
prevalence rates reported. For example, GEMCAS
excluded physicians specialized in diabetology or cardiol-
ogy in an attempt to document prevalence rates in a broad
sample of primary care attendees not being confounded
by a large group of multimorbid patients attending a spe-
cialized physician. Secondary to this, the difference may
be related to the fact that more diabetic patients were
included in DETECT (14.6% vs. 12.4%) and patients were
slightly older 53.9 vs. 51.7 years. Data from another
source became recently available from the global IDEA
study in primary care in 63 countries [27,28]. The data
show a fairly consistent prevalence of overweight all over
the world with substantial differences in obesity preva-
lence. Whether this observation could also be due to dif-
ferent BMI thresholds that may apply in particularly Asian
countries is a matter of debate.
Waist circumference in the overweight
There is some confusion both from the physician and
patient perspective as to being overweight measured by
BMI indicates an increased cardiovascular risk. A modest
elevation of BMI may be simply due to a higher muscle
mass, at least in younger male patients. We were therefore
interested to assess if and to what extent WC is suitable to
discriminate between normal and elevated risk. The data
from the present study clearly show that even in the sub-
group of overweight as well as in the subgroup of normal
weight patients there is a proportion of patients with an
elevation of waist circumference and an unfavourable car-
diovascular risk profile. This could guide both physicians
and patients towards more aggressively lowering
increased body fat in high risk patients with overweight
also.
Earlier studies have focussed on whether BMI, abdominal
obesity or measures like waist-to-height ratio (WHtR) or
waist-to-hip ratio (WHR) may be best to describe an
excess of fat and its relation to cardiovascular risk [1]. Sev-
eral studies have described that WC is a better predictor of
cardiovascular risk outcome than BMI [5-8]. While this
debate is very valid, the mostly used measure of obesity in
primary care is still BMI for which both components
(weight, height) are easy and not offensive to determine.
Given this standard, it is reassuring to know that normal-
weight patients generally have a normal WC and a normal
cardiovascular risk. On the other hand, obese persons
have a high WC and a high cardiovascular risk. For the
group of patients in between, however, it is necessary to
measure WC to determine body fat distribution, since
31% of male and 54% of female patients have a high WC
when in the overweight category by BMI. As shown in
Table 2 &3 most risk factors are significantly elevated in
overweight patients with a high WC, the high cut point
showing the highest PRRs (stratified into age group and
gender). Tables 4 and 5 nicely illustrate that it is particu-
larly hazardous to have a low to moderate BMI but a high
degree of abdominal obesity. A higher BMI with a low
waist circumference on the other hand may point at indi-
viduals with either a more favourable fat distribution or a
higher muscle mass (particularly in overweight male
patients).
Strength and limitations
Despite the strengths of the study (sample size, represent-
ativeness for patients in primary care, simultaneous cover-
age of structural, doctors and patients perspective) two
limitations need to be highlighted: While the data set is
representative for the primary care population it may be
less so for the general population. The degree of represent-
ativeness of the GEMCAS sample for primary care has
been reported in more detail by Moebus et al. [11]. In
short, 2,600 out of the 17,271 initially contacted primary
health care practices responded to the invitation to partic-
ipate in the study (15% response). The response rate var-
ied slightly in the different postal code areas but no
differences greater than ± 2% between contacted and par-
ticipating sites for each region could be observed. The first
2,070 response faxes were collected and analyzed for eli-
gibility. These revealed 1,835 eligible physicians out of
which the first 1,700 were recruited for participation.
Among these, 140 cancelled their participation before
starting the study, mainly due to time-related issues, com-
munication problems or illness. 33 of the 1,835 originally
eligible physicians were recruited in a second run to
replace cancellations among the 1,700. The second limita-
tion was that the Body Mass Index was self-reported in 2/
3rd of the patients in GEMCAS. This may indicate, that the
prevalences reported are likely lower bound estimates for
the true prevalence in this population [29].BMC Public Health 2008, 8:282 http://www.biomedcentral.com/1471-2458/8/282
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Conclusion
There is a high prevalence of obesity and in particular
abdominal obesity among patients in primary health care
in Germany. The determination of the BMI is sufficient to
assess cardiovascular risk in obese patients (because BMI
and WC measurements generally match well in these
patients groups). Using WC however allows to identify
high risk patients from within the overweight and even
normal weight patient group. This approach may help to
build on the educational activities to establish BMI as a
marker for obesity and allows the more appropriate coun-
selling in patients whose overweight is actually abdomi-
nal obesity.
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